Related references
Note: Only part of the references are listed.Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies
Denise Haslwanter et al.
CELL HOST & MICROBE (2022)
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
Elena Gianchecchi et al.
VACCINES (2022)
Yellow fever surveillance suggests zoonotic and anthroponotic emergent potential
Alisa Aliaga-Samanez et al.
COMMUNICATIONS BIOLOGY (2022)
The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis
Akuoma U. Nwaiwu et al.
BMC INFECTIOUS DISEASES (2021)
Yellow fever in Asia-a risk analysis
Bethan Cracknell Daniels et al.
JOURNAL OF TRAVEL MEDICINE (2021)
The interplay between environmental factors, vector competence and vaccine immunodynamics as possible explanation of the 2019 yellow fever re-emergence in Nigeria
I. N. Abdullahi et al.
NEW MICROBES AND NEW INFECTIONS (2021)
Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling
Kevin Jean et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Yellow fever control: current epidemiology and vaccination strategies
Lin H. Chen et al.
TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES (2020)
Epizootics due to Yellow Fever Virus in Sao Paulo State, Brazil: viral dissemination to new areas (2016-2017)
Mariana Sequetin Cunha et al.
SCIENTIFIC REPORTS (2019)
Quantifying model evidence for yellow fever transmission routes in Africa
Katy A. M. Gaythorpe et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
A yellow flag on the horizon: The looming threat of yellow fever to North America
Rodrigo Jacome et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences
Clarissa de Castro Ferreira et al.
EXPERT REVIEW OF VACCINES (2018)
The reemergence of yellow fever
Alan D. T. Barrett
SCIENCE (2018)
Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and YF-VAX) in a Phase III multicenter, double-blind clinical trial
TP Monath et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)